Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03573310
Title A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications

B-cell lymphoma

Advanced Solid Tumor

myelodysplastic syndrome

Therapies

JNJ-64619178

Age Groups: adult | senior
Covered Countries USA | ESP | DEU | CAN

Facility Status City State Zip Country Details
Florida Specialist and Cancer Institute Sarasota Florida 34232 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Ohio State University Columbus Ohio 43210 United States Details
University of Texas, MD Anderson Cancer Center Houston Texas 77030 United States Details
University of Toronto Toronto M5G1Z5 Canada Details
St. Paul's Hospital Vancouver V6E 1M7 Canada Details
Universitaetsklinikum Duesseldorf Düsseldorf 40225 Germany Details
Goethe Universität Frankfurt Frankfurt/Main 60590 Germany Details
Universitatsklinikum Leipzig Leipzig 04103 Germany Details
Carmel Medical Center Haifa 34362 Israel Details
Hadassah Medical Center Jerusalem 9112001 Israel Details
Tel Aviv Sourasky MC Tel Aviv 6423906 Israel Details
Hosp. Univ. Germans Trias I Pujol Badalona 08916 Spain Details
Hosp. Univ. Vall D Hebron Barcelona 08035 Spain Details
Hosp. Univ. Fund. Jimenez Diaz Madrid 28040 Spain Details
Clinica Univ. de Navarra Pamplona 31008 Spain Details
Hosp. Clinico Univ. de Salamanca Salamanca 37007 Spain Details
Hosp. Virgen Del Rocio Sevilla 41013 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field